Instron E3000 load frame controller retrofit
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring a retrofit upgrade for an aging Instron E3000 electrodynamic load frame controller to modernize the system and restore its reliability. The existing equipment, more than 10 years old, is experiencing hardware malfunctions and failures that are costly and difficult to repair; replacement parts are scarce or unavailable, limiting manufacturer support and operational dependability for FDA researchers. The estimated solicitation release date is May 1, 2027, with an estimated award date of July 1, 2027.
The estimated award value ranges from $25,000 to $250,000. The retrofit will ensure the load frame system can be serviced and repaired reliably for years to come. Inquiries may be directed to the Food and Drug Administration's acquisition mailbox at cdhracquisitions@fda.hhs.gov.
Forecast text
Our Instron E3000 electrodynamic load frame is aging (more than 10 years old). Hardware is beginning to malfunction and fail, necessitating costly and lengthy repairs. Repair parts are difficult to source, if they are available at all. Together, this makes the machine difficult to support and service by the manufacturer, and difficult to rely on for FDA researchers. The manufacturer offers a retrofit upgrade which modernizes the load frame system. This will restore the reliability of the load frame system, and ensure it can be serviced and repaired for years to come.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast